Literature DB >> 30320442

Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A interventions in children with spastic cerebral palsy.

Simon-Henri Schless1,2, Francesco Cenni2,3, Lynn Bar-On1,4, Britta Hanssen1,2, Barbara Kalkman5, Thomas O'brien5, Erwin Aertbeliën3, Anja Van Campenhout2,6, Guy Molenaers6,7, Kaat Desloovere1,2.   

Abstract

AIM: This cross-sectional investigation evaluated whether recurrent botulinum neurotoxin A (BoNT-A) interventions to the medial gastrocnemius have an influence on muscle morphology, beyond Gross Motor Function Classification System (GMFCS) level.
METHOD: A cohort of typically developing children (n=67; 43 males, 24 females; median age 9y 11mo [range 7y 10mo-11y 6mo]), a cohort of children with spastic cerebral palsy (CP) naive to BoNT-A interventions (No-BoNT-A; n=19; 10 males, nine females; median age 9y 3mo [range 8y 5mo-10y 10mo]) and a cohort of children with spastic CP with a minimum of three recurrent BoNT-A interventions to the medial gastrocnemius (BoNT-A; n=19; 13 males, six females; median age 9y 8mo [range 7y 3mo-10y 7mo]) were recruited. Three-dimensional freehand ultrasound was used to estimate medial gastrocnemius volume normalized to body mass and echo-intensity.
RESULTS: Normalized medial gastrocnemius volume and echo-intensity significantly differed between the two spastic CP cohorts (p≤0.05), with the BoNT-A cohort having larger alterations. Associations between normalized medial gastrocnemius volume and echo-intensity were highest in the No-BoNT-A cohort, followed by the BoNT-A cohort. Multiple regression analyses revealed that both GMFCS level and BoNT-A intervention history were significantly associated with smaller normalized medial gastrocnemius volume and higher echo-intensity.
INTERPRETATION: Recurrent BoNT-A interventions may induce alterations to medial gastrocnemius volume and echo-intensity beyond the natural history of the spastic CP pathology. WHAT THIS PAPER ADDS: In spastic cerebral palsy, medial gastrocnemius volumes are smaller and echo-intensities higher compared with typical development. Alterations after botulinum neurotoxin A intervention (BoNT-A) are larger than in no BoNT-A intervention. Gross Motor Function Classification System level and BoNT-A history significantly associate with medial gastrocnemius and echo-intensity alterations.
© 2018 Mac Keith Press.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30320442     DOI: 10.1111/dmcn.14056

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  10 in total

1.  Authors' Reply to K. Langdon and Colleagues' Comment on: "Botulinum Toxin in the Management of Children with Cerebral Palsy".

Authors:  Iqbal Multani; Jamil Manji; Tandy Hastings-Ison; Abhay Khot; Kerr Graham
Journal:  Paediatr Drugs       Date:  2019-12       Impact factor: 3.022

2.  Does ultrasound imaging of the spastic muscle have an additive effect on clinical examination tools in patients with cerebral palsy?: A pilot study.

Authors:  Kardelen Gencer Atalay; Evrim Karadag Saygi; Firat Akbas; Ozge Kenis Coskun; Ahmet Hamdi Akgulle; Ilker Yagci
Journal:  North Clin Istanb       Date:  2022-03-11

Review 3.  Over 25 Years of Pediatric Botulinum Toxin Treatments: What Have We Learned from Injection Techniques, Doses, Dilutions, and Recovery of Repeated Injections?

Authors:  Heli Sätilä
Journal:  Toxins (Basel)       Date:  2020-07-06       Impact factor: 4.546

4.  Comprehensive evaluation of gait, spasticity, and muscle morphology: A case report of a child with spastic paresis treated with Botulinum NeuroToxin-A, serial casting, and physiotherapy.

Authors:  Guido Weide; Lizeth Sloot; Laura Oudenhoven; Richard T Jaspers; Jaap Harlaar; Annemieke Buizer; Lynn Bar-On
Journal:  Clin Case Rep       Date:  2019-07-21

5.  Muscle Characteristics in Pediatric Hereditary Spastic Paraplegia vs. Bilateral Spastic Cerebral Palsy: An Exploratory Study.

Authors:  Nathalie De Beukelaer; Lynn Bar-On; Britta Hanssen; Nicky Peeters; Sandra Prinsen; Els Ortibus; Kaat Desloovere; Anja Van Campenhout
Journal:  Front Neurol       Date:  2021-02-26       Impact factor: 4.003

Review 6.  Typical m. triceps surae morphology and architecture measurement from 0 to 18 years: A narrative review.

Authors:  Matthew Bell; Ghaliya Al Masruri; Justin Fernandez; Sîan A Williams; Anne M Agur; Ngaire S Stott; Behzad Hajarizadeh; Ali Mirjalili
Journal:  J Anat       Date:  2021-11-08       Impact factor: 2.610

7.  Reduced Cross-Sectional Muscle Growth Six Months after Botulinum Toxin Type-A Injection in Children with Spastic Cerebral Palsy.

Authors:  Nathalie De Beukelaer; Guido Weide; Ester Huyghe; Ines Vandekerckhove; Britta Hanssen; Nicky Peeters; Julie Uytterhoeven; Jorieke Deschrevel; Karen Maes; Marlies Corvelyn; Domiziana Costamagna; Ghislaine Gayan-Ramirez; Anja Van Campenhout; Kaat Desloovere
Journal:  Toxins (Basel)       Date:  2022-02-14       Impact factor: 4.546

8.  Progressive resistance training for children with cerebral palsy: A randomized controlled trial evaluating the effects on muscle strength and morphology.

Authors:  Britta Hanssen; Nicky Peeters; Nathalie De Beukelaer; Astrid Vannerom; Leen Peeters; Guy Molenaers; Anja Van Campenhout; Ellen Deschepper; Christine Van den Broeck; Kaat Desloovere
Journal:  Front Physiol       Date:  2022-10-04       Impact factor: 4.755

Review 9.  Stretching Interventions in Children With Cerebral Palsy: Why Are They Ineffective in Improving Muscle Function and How Can We Better Their Outcome?

Authors:  Barbara M Kalkman; Lynn Bar-On; Thomas D O'Brien; Constantinos N Maganaris
Journal:  Front Physiol       Date:  2020-02-21       Impact factor: 4.566

Review 10.  Muscle architecture, growth, and biological Remodelling in cerebral palsy: a narrative review.

Authors:  Geoffrey G Handsfield; Sîan Williams; Stephanie Khuu; Glen Lichtwark; N Susan Stott
Journal:  BMC Musculoskelet Disord       Date:  2022-03-10       Impact factor: 2.362

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.